EP1963481A2 - Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1 - Google Patents
Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1Info
- Publication number
- EP1963481A2 EP1963481A2 EP05818740A EP05818740A EP1963481A2 EP 1963481 A2 EP1963481 A2 EP 1963481A2 EP 05818740 A EP05818740 A EP 05818740A EP 05818740 A EP05818740 A EP 05818740A EP 1963481 A2 EP1963481 A2 EP 1963481A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- dha
- acid
- producing
- strains
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020669 docosahexaenoic acid Nutrition 0.000 title claims abstract description 62
- 241001467333 Thraustochytriaceae Species 0.000 title abstract description 32
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 title abstract description 4
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 title abstract description 4
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 title abstract description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 116
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 57
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 23
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 22
- 229930195729 fatty acid Natural products 0.000 claims abstract description 22
- 239000000194 fatty acid Substances 0.000 claims abstract description 22
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 18
- 244000005700 microbiome Species 0.000 claims description 12
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 11
- 108020004463 18S ribosomal RNA Proteins 0.000 claims description 10
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 8
- 241000233675 Thraustochytrium Species 0.000 claims description 4
- 239000000543 intermediate Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 23
- 238000000034 method Methods 0.000 abstract description 7
- 210000003705 ribosome Anatomy 0.000 abstract description 7
- 238000012216 screening Methods 0.000 abstract description 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 31
- 229940013317 fish oils Drugs 0.000 description 9
- 241000251468 Actinopterygii Species 0.000 description 8
- 235000019688 fish Nutrition 0.000 description 8
- 239000002028 Biomass Substances 0.000 description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 5
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 241000120622 Rhizophoraceae Species 0.000 description 4
- 241000233671 Schizochytrium Species 0.000 description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 4
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108020001027 Ribosomal DNA Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000592342 Tracheophyta Species 0.000 description 3
- 210000001787 dendrite Anatomy 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000598397 Schizochytrium sp. Species 0.000 description 2
- 241000269821 Scombridae Species 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 210000002816 gill Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000020640 mackerel Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N n-heptadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 241000200158 Amphidinium Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241000199913 Crypthecodinium Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000862501 Kandelia candel Species 0.000 description 1
- 241001491672 Labyrinthulaceae Species 0.000 description 1
- 241000276495 Melanogrammus aeglefinus Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000519590 Pseudoalteromonas Species 0.000 description 1
- 240000002044 Rhizophora apiculata Species 0.000 description 1
- 240000003793 Rhizophora mangle Species 0.000 description 1
- 241000276448 Salvelinus namaycush Species 0.000 description 1
- 241000233673 Schizochytrium aggregatum Species 0.000 description 1
- 241000863430 Shewanella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000592344 Spermatophyta Species 0.000 description 1
- 241001298226 Ulkenia sp. Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical class CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
- 150000002066 eicosanoids Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000000769 gas chromatography-flame ionisation detection Methods 0.000 description 1
- 210000004884 grey matter Anatomy 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 244000059217 heterotrophic organism Species 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 238000013081 phylogenetic analysis Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
- C12N1/105—Protozoal isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/12—Unicellular algae; Culture media therefor
- C12N1/125—Unicellular algae isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/89—Algae ; Processes using algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/90—Protozoa ; Processes using protozoa
Definitions
- DHA Docosahexaenoic acid
- the invention relates to the screening of a novel unreported strain of Thraustochytrid - SCl producing comparable amounts of Docosahexaenoic acid isolated from the backwaters of Goa by the Pollen baiting method.
- the fatty acid profiles of the isolated organism indicating the production of the omega-3 fatty acids in significant amounts are disclosed. Also revealed is the 18S rRNA sequence of the isolated organisms indicative of their molecular phylogeny.
- PUFAs polyunsaturated fatty acids
- Polyunsaturated fatty acids are long chain fatty acids containing two or more double bonds. Interest in them arises from their potential in therapeutic, food and nutritional applications. They are produced commercially from the selected seed plants and some marine sources. But the production of the purified PUFAs from the current sources will become inadequate for supplying the expanding market ( Gill and Valivety 1997). In order to meet the expected rise in demand and to circumvent the drawbacks of fish oils, alternative production processes for the PUFAs are currently being developed.
- PUFAs are grouped in 2 series on the basis of the position of the terminal bond being 3 C or 6C from the terminal carbon atom of the fatty acid chain. They are generally classified into 2 main groups, the omega-6 (c ⁇ 6 or n-6) and omega-3 ( ⁇ 3 or n-3 series). Of the omega-6 fatty acids, arachidonic acid is gaining particular importance as it is the major precursor of many prostaglandins and eicosanoids and among the omega-3 fatty acids, Docosahexaenoic acid is currently receiving much attention and have been termed as "Essential Fatty Acids". Docosahexaenoic acid (DHA), the unsaturated, 22-carbon long, omega-3 fatty acid is commonly found in fish and marine plants.
- DHA Docosahexaenoic acid
- PUFAs can be obtained from microorganisms.
- the marine algae are thought to be the primary producers of the omega-3 polyunsaturated fatty acids in the marine food chain.
- These marine microorganisms represent the greatest percentage of the undescribed marine species (Colwell 1997) of which the marine microalgae form a large potential source of Docosahexaenoic acid.
- the potential source of n-3 oils is the group of micro-heterotrophs called Thraustochytrids. These are a group of non-photosynthetic, heterotrophic organisms presently classified under the Stramenophila kingdom, together with oomycetes and labyrinthulids.
- Thraustochytrids are the common name of the microheterotrophs that feed as saprobes or occasionally as parasites. Thraustochytrids have a wide geographical distribution with strains isolated from Antarctica, North Sea, India, Japan and Australia. (Reviewed by Lewis et al., 1999).They are rarely found on living plants and appear to be inhibhited by plant anti-microbial agents. Members of these groups are often abound on dead autochthonous as well as allochthonous plant material such as macro algae and submerged Mangrove leaves. They are common in the neritic and the oceanic water column and the sediments including the deep sea.
- microbes can provide a stable supply of fatty acids that can easily mass produced, have a less fishy smell and highly purified DHA and other PUFAs.
- DHA and other PUFAs Several recent studies have catalogued the ability of thraustochytrids strains to produce
- Schizochytrium aggregatum produced a biomass of 0.9g per litre after IOdays (Vazhappilly and Chen,1998), while a biomass of 48g per litre after 4 days was achieved using Schizochytrium sp. SR21 (yaguchi et al., 1997). It is very clear that development of a microbial PUFA production process requires the selection of the proper microorganism and the optimized culture techniques.
- PUFA production The types and the amounts of the PUFAs produced by individual strains of thraustochytrids are susceptible to manipulation by varying culture conditions. Enhancement of the PUFA profiles using molecular techniques may also be considered. Different markets will provide demand for strains that produce high levels of PUFAs measured either in terms of the biomass (i.e., PUFA production w/w cell mass) or volume (i.e., Production w/v fermentation medium).
- Schizochytrium sp. is used to produce DHA by heterotrophic cultivation (OmegaTech, Boulder, Colorado, USA).
- a major drawback of the Schizochytrium strains is the production of the omega-6 docosapentaenoic acid (DPA) in the microbial oils, in addition to DHA (Nakhara et al.1996: Yokochi et al.1998: Ratledge 2001).
- DPA omega-6 docosapentaenoic acid
- the nutraceutical properties of DPA are currently not well known and therefore its presence in oils for food and pharmaceutical applications is undesirable. Separation of DPA from DHA is difficult and expensive.
- the present invention relates to the isolation of several strains of thraustochytrids, a few strains of which produce significant amounts of Docosahexaenoic acid (DHA; C22:6, n- 3) that were screened from the dead leaves and dendrites of marine vascular plants called Mangroves collected from the backwaters of Goa. These strains will have major significance for the commercial production of Docosahexaenoic Acid.
- DHA Docosahexaenoic acid
- Huang et al. have described the grouping of newly isolated docosahexaenoic acid producing thraustochytrids based on their polyunsaturated fatty acid profiles and the comparative analysis of the 18S rRNA genes. Seven strains of marine microbes producing a significant amount of DHA were screened from the seawater collected in coastal areas of Japan and Fiji. They accumulate their intermediate respiratory intermediate fatty acids in addition to DHA. These isolates were proved to be new thraustochytrids by their specific insertion sequences in the 18S rRNA genes.
- the phylogenetic tree constructed by the molecular analysis of the 18S rRNA genes from the isolates and the typical thraustochytrids shows that the strains with the same PUFA profile form each monophyletic cluster. These results suggest that the C20-22 PUFA profile may be appreciable as an eefective characteristic for grouping thraustochytrids.
- the medium producing 28.1- 41.1% of the total fatty acids, for all strains, with the exception of the Ulkenia sp. KF13.
- the DHA yield of the Schizochytrium mangrovie ranged from 747.7 to 2778.9 mg/L after 52 hours of fermentation at 25C.
- the publication titled "Profiles of polyunsaturated fatty acids produced by Thraustochytrium sp KK 17-3 " relates to the isolation of more than 300 strains of microorganisms producing polyunsaturated fatty acids (PUFA) were newly isolated from the coastal seawater in the Seto Inland Sea and around the Iromote Island, Japan, by the baiting method.
- the profiles of PUFA from the DHA producing strains were classified into four types.
- KKl 7-3 was then chosen for further study owing to its high DHA content.(52.1% of the total fatty acid.) and a wide range of other PUFAs including arachidonic, eicosapentaenoic acid and docosapentaenoic acid as well as DHA.
- PUFAs including arachidonic, eicosapentaenoic acid and docosapentaenoic acid as well as DHA.
- Molecular phylogenetic analysis of the 18S rRNA gene sequences showed KK17-3 to be a thraustochytrids.
- the publication titled " Fatty acid composition and the Squalene content of the Marine micro algae Schizochytrium mangrovie” relates to the identification of the fatty acid composition and the squalene content in the thraustochytrids S. mangrovie that was newly isolated from the decaying Kandelia candel leaves in the Hong Kong mangrove habitat.
- the major fatty acid constituents in all the three mangrovie strains were tetradecanoic acid, hexadecanoic acid, docosapentanoic acid, and docosahexaenoic acid.
- DHA was the most predominant polyunsaturated fatty acid and the percentage of DHA (of total fatty acids) in all these strains varied from 32.29 to 39.14%.
- the patent No WO9801536 describes the microorganisms belonging to the genus Shewanella or pseudoalteromonas which can produce docosahexaenoic acid within a short culture period.
- Our invention relates to identification of 10 unreported strains of Thraustochytrids inhabiting in the dead leaves and the dendrites of marine vascular plants called Mangroves from the backwaters of Goa. Subsequent to isolation, GC-MS analysis for the organisms were carried out to determine their total fatty acid content. The 18S rRNA sequences of these organisms indicate their phylogeny. On futher study, these organisms can be efficient large scale producers of Docosahexaenoic acid.
- Seq ID 1 represents the 18S rRNA sequence of SCl Seq ID 2: represents the 18S ribosomal sequence of AVEl Seq ID 3: represents the 18S ribosomal sequence of AVE2 Seq ID 4: represents the 18S ribosomal sequence of AVE3 Seq ID 5: represents the 18S ribosomal DNA sequence of AVE4 Seq ID 6: represents the 18S ribosomal DNA sequence of AVE5 Seq ID 7: represents the 18S ribosomal sequence of AVE6 Seq ID 8: represents the 18S ribosomal sequence of AVE7 Seq ID 9: represents the 18S ribosomal DNA sequence of AVE8.
- Seq ID 10 represents the 18S ribosomal sequence of AVE9. Detailed description of the Invention:
- Thraustochytrium strains are inhabited in the dead leaves and dendrites of marine vascular plants called Mangroves. Dead leaves from these plants were collected from the backwaters of Goa and isolated by pollen baiting method. The leaves were cultured in sterile seawater with antibiotics (streptomycin and penicillin) and pine pollen grains for three days. These pollens were re-inoculated into fresh sterile seawater with antibiotics. After 3 days of incubation the pollens were examined under the microscope.
- antibiotics streptomycin and penicillin
- thraustochytrids 10 different strains of thraustochytrids were found and these were plated on MV (Rock salt -3.4%, Peptone - 0.15%, Yeast Extract- 0.1%, Glucose-2%, KH 2 PO 4 - 0.025%, pH 7) agar plate for 5 days with antibiotics. The thraustochytrids form colony/ layer on the plate. These Thraustochytrids were inoculated in fresh MV media with antibiotics. After 3 days of growth the pure culture were obtained. Thraustochytrids were cultured for a period of 5 days and the cells subjected to GC-MS analysis for determining the total fatty acid content.
- MV Rock salt -3.4%, Peptone - 0.15%, Yeast Extract- 0.1%, Glucose-2%, KH 2 PO 4 - 0.025%, pH 7
- the thraustochytrids form colony/ layer on the plate.
- Total lipid was extracted from the cultures using Folch method of extracting with 2:1 v/v of chloroform: methanol.
- an internal standard heptadecanoic or pentadecanoic acid
- Fatty acids were extracted, esterified and GC-MS analysis was carried out with Agilent 6890 N gas chromatograph connected to Agilent 5973 mass spectrometer and GC on HP 6850 Series gas chromatograph equipped with a FID detector.
- the GC-MS detection was performed at 70 eV (m/z 50-550; source" at 230 0 C and quadruple at 150 0 C) in the EI mode with a capillary column (30 m, HP-5ms, WCOT, i.d. 0.25 mm, film thickness 0.25 ⁇ m, oven 2 min at 150 °C, 6 0 C min "1 to 300 °C, 20 min at 300 °C, Helium carrier gas flow, 1.0 ml/min, split ratio 50:1).
- the capillary column DB-23 (30m, WCOT, i.d. 0.25 mm, film thickness 0.5 ⁇ m) was used.
- the oven temperature was programmed as 2 min at 160 0 C, 6 0 C min '1 to 180 0 C, 2 min at 180 °C, 4 0 C min "1 to 230 °C and 10 min at 230 °C, with N 2 carrier gas flow, 1.5 ml/min, and injector temp at 230 °C and detector temp at 250 °C; split ratio 50:1.
- the fatty acid profile of the 10 strains isolated is represented in the Fig.l
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Botany (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2005/003934 WO2007068997A2 (en) | 2005-12-16 | 2005-12-16 | Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1963481A2 true EP1963481A2 (en) | 2008-09-03 |
Family
ID=37890412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05818740A Pending EP1963481A2 (en) | 2005-12-16 | 2005-12-16 | Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1963481A2 (zh) |
JP (1) | JP2009519032A (zh) |
CN (1) | CN101370929A (zh) |
AU (1) | AU2005339110A1 (zh) |
BR (1) | BRPI0520823A2 (zh) |
CA (1) | CA2639071A1 (zh) |
IL (1) | IL192162A0 (zh) |
MX (1) | MX2008007860A (zh) |
WO (1) | WO2007068997A2 (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5886511B2 (ja) | 2005-06-07 | 2016-03-16 | ディーエスエム ニュートリショナル プロダクツ アーゲーDSM Nutritional Products AG | 脂質および抗酸化剤の製造のための真核微生物 |
WO2008129358A2 (en) | 2006-08-01 | 2008-10-30 | Ocean Nutrition Canada Ltd. | Oil producing microbes and methods of modification thereof |
EP2367950B1 (en) | 2008-12-01 | 2017-03-29 | Universität des Saarlandes | Production of omega-3 fatty acids by myxobacteria |
WO2010097809A2 (en) * | 2009-02-25 | 2010-09-02 | V.B. Medicare Pvt. Ltd. | Improved methods for fermentative production of docosahexaenoic acid |
US8207363B2 (en) | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
KR20150013667A (ko) | 2010-01-19 | 2015-02-05 | 디에스엠 아이피 어셋츠 비.브이. | 에이코사펜타엔산 생산 미생물, 지방산 조성물 및 이의 제조방법 및 용도 |
KR101147451B1 (ko) * | 2010-05-04 | 2012-05-21 | 한국생명공학연구원 | Thraustochytrid계 미세조류의 배양방법 |
EP2390343A1 (en) | 2010-05-31 | 2011-11-30 | InterMed Discovery GmbH | Production of fatty acids by heterologous expression of gene clusters from myxobacteria |
CA2842272C (en) | 2011-07-21 | 2020-04-28 | Dsm Ip Assets B.V. | Fatty acid compositions |
US20140323569A1 (en) * | 2011-07-21 | 2014-10-30 | Krishna Raman | Microbial oils enriched in polyunsaturated fatty acids |
ES2762618T3 (es) | 2013-01-18 | 2020-05-25 | Kyowa Hakko Bio Co Ltd | Microorganismos que producen ácido docosahexaenoico y utilización de los mismos |
FR3001736B1 (fr) * | 2013-02-06 | 2016-03-04 | Roquette Freres | Biomasse de la microalgue schizochytrium mangrovei et son procede de preparation |
CN105189740B (zh) | 2013-03-13 | 2019-01-15 | 帝斯曼营养品股份公司 | 工程化微生物 |
CN103725617A (zh) * | 2014-01-01 | 2014-04-16 | 北京大学深圳研究生院 | 一株富含甘油酯型DHA的破囊壶菌Aurantiochytrium sp.及其应用 |
AU2015263881B2 (en) * | 2014-05-22 | 2020-06-18 | Synthetic Genomics, Inc. | Labyrinthulomycete strains for producing docosahexaenoic acid |
US9890402B2 (en) | 2015-01-24 | 2018-02-13 | Indian Oil Corporation Limited | Thraustochytrid based process for treating waste effluents |
AR104042A1 (es) | 2015-03-26 | 2017-06-21 | Mara Renewables Corp | Producción de alta densidad de biomasa y aceite utilizando glicerol en bruto |
MX2018000502A (es) | 2015-07-13 | 2018-09-07 | Mara Renewables Corp | Mejora del metabolismo de microalga de xilosa. |
US10851395B2 (en) | 2016-06-10 | 2020-12-01 | MARA Renewables Corporation | Method of making lipids with improved cold flow properties |
BR112019012421A2 (pt) * | 2016-12-22 | 2020-02-27 | MARA Renewables Corporation | Cultura, microrganismo eucariótico, métodos para fazer uma composição lipídica e para produzir uma biomassa rica em proteínas |
KR102100650B1 (ko) * | 2018-06-29 | 2020-04-16 | 씨제이제일제당 주식회사 | 신규한 트라우즈토카이트리움 속 균주, 및 이를 이용한 다중불포화지방산 생산방법 |
EP4180513A1 (en) * | 2021-11-15 | 2023-05-17 | Indian Oil Corporation Limited | An improved process for production of enriched algal biomass |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998001536A1 (fr) | 1996-07-03 | 1998-01-15 | Sagami Chemical Research Center | Micro-organismes produisant de l'acide docosahexanoique et procede de production de l'acide docosahexanoique |
JP4280158B2 (ja) * | 2002-12-27 | 2009-06-17 | 富士フイルム株式会社 | ドコサヘキサエン酸生産能を有する微生物及びその利用 |
US20050019880A1 (en) * | 2003-03-31 | 2005-01-27 | Council Of Scientific And Industrial Research | Method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists |
-
2005
- 2005-12-16 WO PCT/IB2005/003934 patent/WO2007068997A2/en active Application Filing
- 2005-12-16 CA CA002639071A patent/CA2639071A1/en not_active Abandoned
- 2005-12-16 CN CNA200580052523XA patent/CN101370929A/zh active Pending
- 2005-12-16 AU AU2005339110A patent/AU2005339110A1/en not_active Abandoned
- 2005-12-16 EP EP05818740A patent/EP1963481A2/en active Pending
- 2005-12-16 JP JP2008545118A patent/JP2009519032A/ja active Pending
- 2005-12-16 BR BRPI0520823-8A patent/BRPI0520823A2/pt not_active IP Right Cessation
- 2005-12-16 MX MX2008007860A patent/MX2008007860A/es not_active Application Discontinuation
-
2008
- 2008-06-15 IL IL192162A patent/IL192162A0/en unknown
Non-Patent Citations (1)
Title |
---|
DATABASE EMBL [online] 5 December 2005 (2005-12-05), "Thraustochytriidae sp. NIOS-1 haplotype NIOS1-D00-3 18S ribosomal RNA gene, complete sequence.", retrieved from EBI accession no. EMBL:AY705771 Database accession no. AY705771 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007068997A2 (en) | 2007-06-21 |
CA2639071A1 (en) | 2007-06-21 |
IL192162A0 (en) | 2008-12-29 |
CN101370929A (zh) | 2009-02-18 |
JP2009519032A (ja) | 2009-05-14 |
AU2005339110A1 (en) | 2007-06-21 |
MX2008007860A (es) | 2009-02-11 |
BRPI0520823A2 (pt) | 2011-04-12 |
WO2007068997A3 (en) | 2007-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007068997A2 (en) | Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1 | |
CN103827289B (zh) | 裂殖壶菌诱变方法及其产生的变异株 | |
Perveen et al. | Isolation and characterization of a novel thraustochytrid-like microorganism that efficiently produces docosahexaenoic acid | |
CN1977038B (zh) | 使用最适化的低盐培养基培养Thraustochytriales属微生物的方法 | |
Patel et al. | Emerging prospects of microbial production of omega fatty acids: recent updates | |
JP3425622B2 (ja) | ラビリンチュラ属菌を用いた高度不飽和脂肪酸含有培養物および高度不飽和脂肪酸含有油脂の製造方法 | |
JP4344827B2 (ja) | スキゾキトリウム属の微生物を用いた長鎖高度不飽和脂肪酸含有リン脂質の製造方法 | |
CN102037130A (zh) | 使用网粘菌目微生物来生产含有pufa的油的方法 | |
JP5649785B2 (ja) | 油脂含有物あるいは油脂中のドコサヘキサエン酸含有率を増加する方法 | |
US20170327851A1 (en) | Microalgae Aurantiochytrium sp. LA3 (KCTC12685BP) and Method for Preparing Bio-Oil Using the Same | |
Bagul et al. | Isolation of fast-growing thraustochytrids and seasonal variation on the fatty acid composition of thraustochytrids from mangrove regions of Navi Mumbai, India | |
JP2021168709A (ja) | 高度不飽和脂肪酸、特にオメガ3クラス脂肪酸に富む脂質を含有する原生生物を増殖する方法、及び増殖した原生生物又はその脂質を生産するためのその実施 | |
Hakim | The potential of heterotrophic microalgae (Schizochytrium sp.) as a source of DHA | |
JP2006513713A (ja) | ヤブレツボカビ科原生生物における多価不飽和脂肪酸の含量を高める方法 | |
US20050019880A1 (en) | Method of enhancing levels of polyunsaturated fatty acids in thraustochytrid protists | |
KR20080087820A (ko) | 도코사헥사엔산〔dha〕을 생산하는 트라우스토키트리드균주-sc1 | |
WO2017131188A1 (ja) | 高度不飽和脂肪酸を含む油脂の製造方法 | |
KR102023756B1 (ko) | 신규 트라우스토키트리드〔Thraustochytrid〕 계 미세조류 트라우스토키트리움〔Thraustochytrium〕sp.LA6〔KCTC12389BP〕및 이를 이용한 바이오오일의 생산방법 | |
KR102126441B1 (ko) | 신규한 로보스페라 인시사(Lobosphaera incisa)K-1 미세조류 및 이의 용도 | |
Zhang | The diversity and biotechnological application of marine microbes producing Omega-3 fatty acids | |
Berryman | Isolation of marine protists for production of polyunsaturated fatty acids | |
Hakim | THE POTENTIAL OF HETEROTROPHIC MICROALGAE (Schizochytrium sp.) AS A SOURCE OF DHA Potensi Mikroalga Heterotroph (Schizochytrium sp.) sebagai Sumber DHA | |
MXPA06005296A (en) | Method for the cultivation of microorganisms of the genusthraustochytrialesby using an optimized low salt medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080616 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AVESTHAGEN LIMITED |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AVESTHAGEN LIMITED |
|
17Q | First examination report despatched |
Effective date: 20090113 |
|
DAX | Request for extension of the european patent (deleted) | ||
18D | Application deemed to be withdrawn |
Effective date: 20140701 |
|
D18D | Application deemed to be withdrawn (deleted) | ||
18D | Application deemed to be withdrawn |
Effective date: 20140701 |
|
D18D | Application deemed to be withdrawn (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: AVESTHAGEN LIMITED |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140701 |